Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of MARK2 (unknown origin) by Ambit kinase assay
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Thermal Shift Assay. Domain: start/stop: M1-K331
Assay data:3 Tested
SummaryRelated BioAssays by Target
Inhibition of MARK2 (unknown origin) at 1 uM relative to control
Assay data:2 Tested
MARK2 DiscoveRx kinase panel
PAR-1Balpha(h) Kinase panel
Inhibition of MARK2 (unknown origin) at 1 uM
PAR-1 FLIPR Assay from US Patent US9701669: "Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists"
Assay data:11 Active, 11 Activity ≤ 1 µM, 11 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
KinomeScan assay: inhibition of MARK2
Assay data:108 Tested
MARK2(MAR2LGY1) Takeda global kinase panel
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
PAR-1Balpha(h) Eurofins kinase panel
MARK2 ProQinase selectivity panel
MARK2 Kinase screen
Invitrogen kinase screen (MARK2)
MARK2 Invitrogen selectivity data (BI)
PAR-1Balpha (h) Upstate kinase activity assay
PAR-1Balpha (h) Eurofins Kinase panel
PAR-1Balpha (h) Millipore kinase activity assay
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on